This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2006-2007.
Company Filing History:
Years Active: 2006-2007
Title: Jan Van Deursen: Innovator in Transgenic Research
Introduction
Jan Van Deursen is a prominent inventor based in Rochester, MN (US). He has made significant contributions to the field of medical research, particularly in the development of transgenic models that aid in understanding various health conditions. With a total of 2 patents, his work has implications for a wide range of medical applications.
Latest Patents
One of Jan Van Deursen's latest patents is related to a transgenic mouse lacking PAPP-A activity. This invention provides materials and methods for creating a transgenic non-human mammal with a disrupted PAPP-A allele. The methods developed can be used to identify and characterize agents that affect conditions related to PAPP-A activity, such as vascular restenosis, atherosclerosis, wound healing, cancer, fibrosis, bone development, fetal development, longevity, and fracture repair. Another significant patent is for IEX-1 knockout animals, which includes methods and materials related to animals with a disrupted IEX-1 sequence. This invention encompasses both homozygous and heterozygous knockout (IEX-1) animals.
Career Highlights
Jan Van Deursen is affiliated with the Mayo Foundation for Medical Education and Research, where he conducts his research. His work has been instrumental in advancing the understanding of genetic factors in various diseases.
Collaborations
Jan has collaborated with notable colleagues, including Rajiv Kumar and Cheryl A Conover, to further enhance the impact of his research.
Conclusion
Jan Van Deursen's innovative work in transgenic research has paved the way for new insights into medical conditions and potential treatments. His contributions continue to influence the field significantly.